Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients

NCT02439554 is registered in ClinicalTrials.gov with Hospital Galdakao-Usansolo as lead sponsor.

NCT NCT02439554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02439554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients
Lead sponsor
Hospital Galdakao-Usansolo
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
June 30, 2017
Enrollment
1,463 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer